Ornet Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 4.50 Cr
as on 23-10-2024
- Company Age 8 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 28.20 Cr
as on 23-10-2024
- Revenue %
(FY 2023)
- Profit -267.35%
(FY 2023)
- Ebitda -278.75%
(FY 2023)
- Net Worth 76.18%
(FY 2023)
- Total Assets 183.80%
(FY 2023)
About Ornet Pharmaceuticals
The Corporate was formerly known as Ishanga Life Science Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹28.20 Cr.
Vivek Jain, Neil Jain, Kalpeshkumar Patel, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24304GJ2016PTC094602
- Company No.
094602
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ornet Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpeshkumar Patel  | Managing Director | 30-Oct-2020 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neil Jain  | Director | 24-Aug-2022 | Current |
| Vivek Jain | Director | 24-Aug-2022 | Current |
| Mital Patel | Director | 30-Oct-2020 | Current |
| Rishi Patel | Director | 30-Oct-2020 | Current |
Financial Performance of Ornet Pharmaceuticals.
Ornet Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 267.35% decrease in profit. The company's net worth Soared by an impressive increase of 76.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ornet Pharmaceuticals?
In 2023, Ornet Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Parima International Private LimitedActive 11 years 2 monthsKalpeshkumar Patel, Mital Patel and 1 more are mutual person
Ornet Intermediates Private LimitedActive 33 years 9 monthsVivek Jain and Neil Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Jan 2023 | ₹14.00 Cr | Open |
Others Creation Date: 16 Jan 2023 | ₹14.00 Cr | Open |
Hdfc Bank Limited Creation Date: 22 Sep 2022 | ₹2.02 M | Open |
How Many Employees Work at Ornet Pharmaceuticals?
Ornet Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ornet Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ornet Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
